What a clawback (DIR fee) is
A clawback is money a PBM or health plan recovers from a pharmacy after a prescription claim has already been paid. In Medicare Part D the formal term is a pharmacy “direct and indirect remuneration” (DIR) fee or price concession: it is post-sale compensation that changes the price the pharmacy ultimately keeps for a drug. Because the recoupment can arrive weeks or months later, the pharmacy’s final, net reimbursement is unpredictable and can land below the pharmacy’s own cost to acquire the drug. Commercial (non-Medicare) plans use similar retroactive recoupments, but those are governed by private PBM contracts rather than the federal Part D rule below.
The Part D reform: concessions at the point of sale
The key federal change is CMS rule CMS-4192-F, finalised in 2022 and effective January 1, 2024. It requires Part D plans to apply all price concessions from network pharmacies to the negotiated price at the point of sale, and redefines that price as the lowest amount the pharmacy could be paid. In practice this folds what used to be a retroactive clawback into the price set when the claim is filled, so the pharmacy sees its floor reimbursement up front instead of a surprise recoupment later. CMS framed the change as lowering patient cost-sharing at the counter and improving transparency, noting that pharmacy price concessions had grown more than 107,400% between 2010 and 2020.
What changed — and what didn’t
The reform makes Part D pharmacy payments more predictable, but it created a one-time cash-flow squeeze that pharmacies called the “DIR cliff”: in early 2024, clawbacks on 2023 claims were still being collected while 2024 claims already paid at the lower point-of-sale price. The rule also does not touch commercial retroactive recoupments, so a clawback dispute outside Part D still turns on contract terms and any applicable state PBM law. Where a recoupment is tied to a disputed reimbursement amount, the relevant remedy may instead be a maximum-allowable-cost appeal. The state tracker records where states have addressed reimbursement and recoupment.